Catalyst Wire Dossier Catalyst Wire Dossier

MNKD-101

Clofazimine inhalation suspension · MannKind Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MNKD-101, covering 2025-11-12 to 2025-11-12. Get the full timeline:

Most recent: Clinical Trial Update: ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension [Phase 3]

See pricing